pyelonephritis | CMAC

pyelonephritis

Ceftolozane/tazobactam – the «new player» in a battle against multiresistant pathogens

Ceftolozane/tazobactam is a new combined antibacterial agent for the treatment of infections caused by gram-negative microorganisms, P. aeruginosa in particular, including strains resistant to other clinically available antimicrobials. In this paper …

Urinary Tract Infections in Diabetic Patients

Urinary tract infections (UTI) in patients with diabetes mellitus are considered complicated UTI. The specific characteristics of UTI in diabetic patients are the following: high prevalence of asymptomatic bacteriuria, involvement of upper urinary …

Antibacterial Therapy of Acute Uncomplicated Cystitis and Pyelonephritis in Adults

The present guidelines for clinical practice suggest preferable approaches to the problem of antibacterial therapy of acute uncomplicated cystitis and pyelonephritis in adults. Classification of urinary tract infections, risk factors, current data on …